Abbott said the FDA has approved its CardioMEMS HERO device – a pulmonary artery (PA) pressure reader – to support the care of people living with heart failure.
The reader contains new design features to help heart failure patients and their clinicians with the daily insights. Abbott said it will soon begin commercial release of the CardioMEMS HERO reader in the United States.
Abbott’s CardioMEMS HERO reader is a new component of the CardioMEMS HF System. The HERO reader is similar in size to a laptop case and is smaller than the system’s previous model. It is designed to work with the CardioMEMS PA Sensor – a paperclip-sized device implanted near the heart where rising PA pressures signal worsening heart failure.
Patients lay with their back centered on the HERO reader for less than 60 seconds on averageii to take a remote PA pressure reading and securely send the data to their care team. Clinicians will receive the daily data readings and if they see changes in PA pressures, they will communicate to the patient any medication or lifestyle changes needed to help slow heart failure progression – often before a patient even feels symptoms – to keep them out of the hospital.
